The Microbiome in Cancer: Composition, Mechanisms, and Therapeutic Implications

ABSTRACT Cancer complexity arises not only from host genetics but also from interactions between the host and microbial communities. However, the field remains fragmented, and a systems‐level framework is needed to guide precision diagnostics and therapy. We develop the “oncobiome” as an integrative framework linking commensal, pathobiont, and tumor‐associated microbial activities to cancer development, progression, and treatment response. We describe how diet, antibiotics, therapy, and environmental factors may shape the shift from microbiome homeostasis to a malignancy‐associated oncobiome. An organ‐specific overview of the oncobiome illustrates how microbial communities interact with systemic microbial, immune, and metabolic networks. Mechanistically, we examine how microbial signals may influence the hallmarks of cancer, including genomic instability, altered tumor metabolism, and immune evasion, as well as epithelial barrier disruption, metastatic progression, and therapeutic resistance. Finally, we assess candidate microbial biomarkers for cancer detection, prognosis, and treatment‐response monitoring, alongside fecal microbiota transplantation, rationally designed microbial consortia, and selected probiotics. We distinguish preliminary anticancer findings from microbiota‐restoration and supportive‐care applications and highlight the need for prospective validation and contamination control. By integrating temporal microbial variation, anatomical niches, and cancer‐relevant functions, this review identifies priorities for development and clinical evaluation of microbiome‐based diagnostics and interventions.

Authors

Institutions

Publication Details

Journal
MedComm
Published
2026-11-17
DOI
https://doi.org/10.1002/mco2.71133
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Microbiome in Cancer: Composition, Mechanisms, and Therapeutic Implications

Ning Lou, Xuan Zhang, Na Wang, Haolong Li et al.
MedComm
Gut microbiota and health
article

The Microbiome in Cancer: Composition, Mechanisms, and Therapeutic Implications

Ning Lou, Xuan Zhang, Na Wang, Haolong Li, Yongzhe Li, Jiyan Dong, Xiaohong Han
article en

Abstract

ABSTRACT Cancer complexity arises not only from host genetics but also from interactions between the host and microbial communities. However, the field remains fragmented, and a systems‐level framework is needed to guide precision diagnostics and therapy. We develop the “oncobiome” as an integrative framework linking commensal, pathobiont, and tumor‐associated microbial activities to cancer development, progression, and treatment response. We describe how diet, antibiotics, therapy, and environmental factors may shape the shift from microbiome homeostasis to a malignancy‐associated oncobiome. An organ‐specific overview of the oncobiome illustrates how microbial communities interact with systemic microbial, immune, and metabolic networks. Mechanistically, we examine how microbial signals may influence the hallmarks of cancer, including genomic instability, altered tumor metabolism, and immune evasion, as well as epithelial barrier disruption, metastatic progression, and therapeutic resistance. Finally, we assess candidate microbial biomarkers for cancer detection, prognosis, and treatment‐response monitoring, alongside fecal microbiota transplantation, rationally designed microbial consortia, and selected probiotics. We distinguish preliminary anticancer findings from microbiota‐restoration and supportive‐care applications and highlight the need for prospective validation and contamination control. By integrating temporal microbial variation, anatomical niches, and cancer‐relevant functions, this review identifies priorities for development and clinical evaluation of microbiome‐based diagnostics and interventions.

MedCommVol. 7(12)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), National Cancer Center (US)
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon